Simultaneous Occurrence of Transitional, Squamous and Adenocarcinoma of the Bladder After 15 Years of Cyclophosphamide Ingestion
- 1 March 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 125 (3) , 424-426
- https://doi.org/10.1016/s0022-5347(17)55061-2
Abstract
A patient is reported who had a urothelial tumor with tri-differentiation into transitional, squamous and adenocarcinoma after ingestion of 285 cyclophosphamide during a 15 yr period. The possibility is again raised that the use of high doses of this drug over long periods may be associated with an increased incidence of carcinoma of the bladder. Frequent cystoscopic examinations may be warranted in patients who have received large cumulative amounts of the drug.This publication has 9 references indexed in Scilit:
- Bladder cancer after cyclopphophamide therapyUrology, 1980
- Bladder cancer following administration of cyclophosphamideUrology, 1980
- The Incidence Of Bladder Cancer after Cyclophosphamide TherapyJournal of Urology, 1979
- Carcinogenic action of low‐dose cyclophosphamide given orally to sprague‐dawley rats in a lifetime experimentInternational Journal of Cancer, 1979
- Does cyclophosphamide induce bladder cancer?Urology, 1978
- Urinary-Bladder Fibrosis and Telangiectasia Associated with Long-Term Cyclophosphamide TherapyNew England Journal of Medicine, 1971
- Cyclophosphamide Hemorrhagic CystitisJournal of Urology, 1967
- Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in manCancer, 1964
- Clinical Evaluation of CyclophosphamidePublished by American Medical Association (AMA) ,1962